Webinar 2 02 October 2025

Under-represented populations in clinical trials

13:00 - 16:00 CET

This session explored how we can shift the mindset of protecting people from research to protecting them through research, and also discussed how clinical trial networks and sponsors are promoting inclusion.

Rewatch the sessions below. You can download the full presentation here.

Session 1: Why are research ethics important?

13:00 - 13:45 CET

Panel discussion on research ethics

Jacqueline Kitulu, Incoming President, World Medical Association
Mercury Shitindo, Chair & Executive Director, Africa Bioethics Network

Speakers

Session 2: Project initiatives supporting inclusivity

13:45 - 14:30 CET

Presentation of project initiatives

Pediatrics & Pregnant Women in Clinical Trials – Mariana Widmer & Martina Penazzato, WHO
Malaria in Mothers and Babies (MiMBa) – Myriam El Gaaloul, Medicines for Malaria Venture
ICH E21: Inclusion of Pregnant and Breast-feeding Individuals in Clinical Trials – Theresa Wang, on behalf of IFPMA

Speakers

Session 3: Perspectives and progress for the inclusion of under-represented populations in clinical trials

14:30 - 16:00 CET

Panel discussion

Mojisola Adeyeye, Director General of National Agency for Food and Drug Administration and Control (NAFDAC)
Jean Marie Vianney Habarugira, Senior Scientific Officer, EDCTP3
Richa Chandra, Clinical Development Head, Global Health, Novartis on behalf of IFPMA
Runcie Chidebe, Founder, Project PINK BLUE